当前位置: 首页 > 期刊 > 《上海医药》 > 202015
编号:13840693
VEGF及其靶向药物的研究进展(5)
http://www.100md.com 2020年5月25日 《上海医药》 202015
     [26] Gaya A, Tse V. A preclinical and clinical review of aflibercept for the management of cancer[J]. Cancer Treat Rev, 2012, 38(5): 484-493.

    [27] Ciombor KK, Berlin J, Chan E. Aflibercept[J]. Clin Cancer Res, 2013, 19(8): 1920-1925.

    [28] Ramlau R, Gorbunova V, Ciuleanu TE, et al. Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized ......
上一页1 2 3 4 5

您现在查看是摘要页,全文长 2832 字符